Related Experiment Video
Updated: Mar 31, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Genomic and Proteomic Characterization of Acute Kidney Injury
1Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Abstract:
The incidence and severity of acute kidney injury (AKI) is rising globally, and the associated morbidity and mortality remain high despite promising advances in experimental therapeutics. The reasons include (a) an incomplete understanding of the complex pathophysiology, (b) an inability to reliably identify risk factors for AKI and (c) a lack of biomarkers for the early prediction of AKI and its outcomes. Functional genomics, bioinformatics and proteomics have begun to uncover candidates that are emerging as biomarkers and therapeutic targets. This review will update the reader on current technologies in genomics (including targeted sequencing, genome wide association studies and transcriptome profiling) and proteomics (including gel electrophoresis and mass spectrometry methods) and their application on human AKI.
Insights
Acute kidney injury (AKI) is increasing worldwide. Genomics and proteomics offer new ways to find biomarkers and targets for better AKI prediction and treatment.
Area of Science:
- Nephrology
- Genomics
- Proteomics
Background:
- Global incidence and severity of acute kidney injury (AKI) are rising.
- High morbidity and mortality persist despite therapeutic advances.
- Incomplete understanding of pathophysiology, risk factors, and lack of early predictive biomarkers hinder progress.
Purpose of the Study:
- To review current genomic and proteomic technologies.
- To discuss their application in human AKI research.
- To highlight emerging biomarkers and therapeutic targets.
Main Methods:
- Review of current technologies in functional genomics: targeted sequencing, genome-wide association studies, transcriptome profiling.
- Review of current technologies in proteomics: gel electrophoresis, mass spectrometry.
- Application of these technologies to human AKI.
Main Results:
- Genomics and proteomics are uncovering potential biomarkers for AKI.
- These approaches are identifying novel therapeutic targets for AKI.
- Advances in technology are improving the ability to study AKI.
Conclusions:
- Genomic and proteomic technologies are crucial for advancing AKI research.
- These 'omics' fields offer promise for early AKI prediction and novel therapeutics.
- Further application of these technologies is essential to combat the rising AKI burden.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management

